[1]
M. Morrison and E. Bicudo, “Producing Value or Responding to Valuation? SMEs’ Strategies for Commercialising Induced Pluripotent Stem Cell and Bioprinting Technology”, S&TS, Mar. 2026, doi: 10.23987/sts.149468.